Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$4.33 - $6.06 $463,080 - $648,098
-106,947 Reduced 67.96%
50,421 $236,000
Q4 2023

Feb 14, 2024

SELL
$3.13 - $5.13 $1.09 Million - $1.79 Million
-349,701 Reduced 68.97%
157,368 $767,000
Q2 2023

Aug 14, 2023

BUY
$5.28 - $8.35 $2.04 Million - $3.23 Million
386,429 Added 320.32%
507,069 $3.75 Million
Q1 2023

May 15, 2023

BUY
$7.6 - $12.68 $726,225 - $1.21 Million
95,556 Added 380.94%
120,640 $987,000
Q4 2022

Feb 14, 2023

SELL
$8.6 - $14.1 $1.85 Million - $3.03 Million
-215,149 Reduced 89.56%
25,084 $240,000
Q3 2022

Nov 14, 2022

SELL
$10.63 - $15.76 $5.08 Million - $7.53 Million
-477,830 Reduced 66.54%
240,233 $2.82 Million

Others Institutions Holding AKYA

About Akoya Biosciences, Inc.


  • Ticker AKYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 37,892,300
  • Market Cap $80M
  • Description
  • Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope...
More about AKYA
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.